Our Times 'relentless disease' against cancer worldwide each year, thousands of billions of dollars to research, conducted in secrecy Urla'daki Izmir High Technology Institute, 3 years, new types of anti-cancer medications reached an important stage.
Molecules synthesized in the laboratory of cell culture İYTE'deki regularly lead to death in cancer cells, while the same kind of anti-cancer drugs appeared to be 80 times more effective. Anti-cancer medication was found in healthy cells has not been damaged. İyaç, immediately after the results of the molecular laboratory mice, and then be tested in clinical environment. If these tests are successful revolution in cancer treatment to live.
Department of Chemistry, Faculty of Science IYTE Asst. Assoc. Dr. Call Ali, with his team 'New Type Anti-cancer medicine Project working on for 3 years, indicating the laboratory phase of the project was successful, said. They continue to express the project in great secrecy and meticulousness Call, "and successfully tested in mice before, which set out to further reinforce a molecule. This molecule have prepared various types. Our lab test result of 80 times more effective than the previous molecules have reached a structure. We have seen a 50 percent cell death in some cancer cells. This death, were regular. Because the main problem in cancer death in cancer cells not go to regularly. As a result we have seen the death of a regular cell. In addition, a solid substance which does not damage the cells have detected, "he said.
Call stating that the project would last for 2 years in mice, and then will start clinical trials, he said. Call recording will be working on at least 10 subjects in clinical trials, "If all goes well the project will complete within 5-6 years. This is not a very long time. In normal circumstances the release of drug in the world discovered a drug takes 14 years," he said.
TUBITAK referenced
Experiments in mice expressing resorted to TUBITAK for the implementation of Call, 350 thousand pounds transferred to the project said that if the approval of TUBITAK. Resorted to the Turkish Patent Institute to get a patent that describes the Call, "have similar studies in the world. However, we use our own methods and receive results. For this reason, we want to protect our work. The next stage of the project with the Ege University Science Technology and Research Center, Anadolu University, Faculty of Pharmacy They decided to enter in, "he said. Rector of Izmir Institute of Technology. Dr. View Güden also to revolutionize the treatment of cancer studies would be of benefit to all mankind, he said.
ADÜ'nün target "Complementary Medicine Centre
Adnan Menderes University's new Rector. Dr. View Birincioğlu, 'Complementary Medicine Centre Project will work to implement as soon as possible, he said. Birincioğlu the center, giving the fight against cancer, and relief of pain patients to increase morale, said that life extension will be provided.
Rector of the new elected in elections held last month, Prof. ADÜ'nün. Dr. The most important project of Mustafa Birincioğlu 'Complementary Medicine Centre is set up announced. Birincioğlu, cancer patients, disease processes, the best way to prolong the life of the center spend much you care by expressing, "Turkey suffers dying patients," he said.
Catch up with YouTube
Birincioğlu said: "You are the cancer patients 'regimen you did, there is nothing I can do now. Go home, wait for death,' say can not finish the treatment. The patient's sleeplessness, misery, view of life, you have to deal with disease. Phytotherapy (herbal treatment ), suburban (hot water therapy), acupuncture prolong the life of a person able to provide any kind of treatment. the world is going towards the creation of such centers. ADÜ'de for the first time within a hospital in Turkey, I want to open such a center. The plants in the center of the active substance rates, the extent to which what is good for diseases, investigate, use. also proficient in the field of complementary medicine to train doctors. "
No comments:
Post a Comment